These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Psychosis in Alzheimer's disease is associated with frontal metabolic impairment and accelerated decline in working memory: findings from the Alzheimer's Disease Neuroimaging Initiative. Koppel J; Sunday S; Goldberg TE; Davies P; Christen E; Greenwald BS; Am J Geriatr Psychiatry; 2014 Jul; 22(7):698-707. PubMed ID: 23672944 [TBL] [Abstract][Full Text] [Related]
5. Quantification of Tau Load Using [ Golla SSV; Timmers T; Ossenkoppele R; Groot C; Verfaillie S; Scheltens P; van der Flier WM; Schwarte L; Mintun MA; Devous M; Schuit RC; Windhorst AD; Lammertsma AA; Boellaard R; van Berckel BNM; Yaqub M Mol Imaging Biol; 2017 Dec; 19(6):963-971. PubMed ID: 28374171 [TBL] [Abstract][Full Text] [Related]
6. Test-Retest Reproducibility for the Tau PET Imaging Agent Flortaucipir F 18. Devous MD; Joshi AD; Navitsky M; Southekal S; Pontecorvo MJ; Shen H; Lu M; Shankle WR; Seibyl JP; Marek K; Mintun MA J Nucl Med; 2018 Jun; 59(6):937-943. PubMed ID: 29284675 [TBL] [Abstract][Full Text] [Related]
7. Associations between quantitative [ Timmers T; Ossenkoppele R; Wolters EE; Verfaillie SCJ; Visser D; Golla SSV; Barkhof F; Scheltens P; Boellaard R; van der Flier WM; van Berckel BNM Alzheimers Res Ther; 2019 Jul; 11(1):60. PubMed ID: 31272512 [TBL] [Abstract][Full Text] [Related]
8. Imaging tau burden in dementia with Lewy bodies using [ Mak E; Nicastro N; Malpetti M; Savulich G; Surendranathan A; Holland N; Passamonti L; Jones PS; Carter SF; Su L; Hong YT; Fryer TD; Williams GB; Aigbirhio F; Rowe JB; O'Brien JT Neurobiol Aging; 2021 May; 101():172-180. PubMed ID: 33631469 [TBL] [Abstract][Full Text] [Related]
13. Correlation of In Vivo [18F]Flortaucipir With Postmortem Alzheimer Disease Tau Pathology. Smith R; Wibom M; Pawlik D; Englund E; Hansson O JAMA Neurol; 2019 Mar; 76(3):310-317. PubMed ID: 30508025 [TBL] [Abstract][Full Text] [Related]
14. Local and distant relationships between amyloid, tau and neurodegeneration in Alzheimer's Disease. Iaccarino L; Tammewar G; Ayakta N; Baker SL; Bejanin A; Boxer AL; Gorno-Tempini ML; Janabi M; Kramer JH; Lazaris A; Lockhart SN; Miller BL; Miller ZA; O'Neil JP; Ossenkoppele R; Rosen HJ; Schonhaut DR; Jagust WJ; Rabinovici GD Neuroimage Clin; 2018; 17():452-464. PubMed ID: 29159058 [TBL] [Abstract][Full Text] [Related]
15. Associations between [ La Joie R; Bejanin A; Fagan AM; Ayakta N; Baker SL; Bourakova V; Boxer AL; Cha J; Karydas A; Jerome G; Maass A; Mensing A; Miller ZA; O'Neil JP; Pham J; Rosen HJ; Tsai R; Visani AV; Miller BL; Jagust WJ; Rabinovici GD Neurology; 2018 Jan; 90(4):e282-e290. PubMed ID: 29282337 [TBL] [Abstract][Full Text] [Related]
17. 18F-Flortaucipir PET Associations with Cerebrospinal Fluid, Cognition, and Neuroimaging in Mild Cognitive Impairment due to Alzheimer's Disease. Okafor M; Nye JA; Shokouhi M; Shaw LM; Goldstein F; Hajjar I J Alzheimers Dis; 2020; 74(2):589-601. PubMed ID: 32065800 [TBL] [Abstract][Full Text] [Related]
18. Regional profiles of the candidate tau PET ligand 18F-AV-1451 recapitulate key features of Braak histopathological stages. Schwarz AJ; Yu P; Miller BB; Shcherbinin S; Dickson J; Navitsky M; Joshi AD; Devous MD; Mintun MS Brain; 2016 May; 139(Pt 5):1539-50. PubMed ID: 26936940 [TBL] [Abstract][Full Text] [Related]
19. The heterogeneity of asymmetric tau distribution is associated with an early age at onset and poor prognosis in Alzheimer's disease. Lu J; Zhang Z; Wu P; Liang X; Zhang H; Hong J; Clement C; Yen TC; Ding S; Wang M; Xiao Z; Rominger A; Shi K; Guan Y; Zuo C; Zhao Q; Neuroimage Clin; 2023; 38():103416. PubMed ID: 37137254 [TBL] [Abstract][Full Text] [Related]